Etodolac, a new nonsteroidal anti-inflammatory drug: Gastrointestinal microbleeding and endoscopic studies
- 1 March 1989
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 8 (S1) , 5-15
- https://doi.org/10.1007/bf02214105
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.Gut, 1987
- Gastrointestinal Blood Loss in Arthritic Patients Receiving Chronic Dosing with Etodolac and PiroxicamThe Lancet Healthy Longevity, 1986
- NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCERThe Lancet, 1986
- AbstractsThe Journal of Clinical Pharmacology, 1985
- Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.Gut, 1985
- Gastrointestinal Microbleeding Associated with the Use of Etodolac, Ibuprofen, Indomethacin, and Naproxen in Normal MalesThe Journal of Clinical Pharmacology, 1984
- Gastrointestinal Blood Loss of Oxaprozin and Aspirin with Placebo ControlThe Journal of Clinical Pharmacology, 1982
- Endoscopic Evaluation of the Effects of Aspirin, Buffered Aspirin, and Enteric-Coated Aspirin on Gastric and Duodenal MucosaNew England Journal of Medicine, 1980
- Comparison of gastrointestinal effects of aspirin and fenoprofenArthritis & Rheumatism, 1979
- An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosaGastrointestinal Endoscopy, 1975